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riophage to the sample of cells (the cells can be isolated from 
complex sample matrices using standard immunomagnetic 
separation techniques or other methods), followed by assay- 
ing for the reporter protein. This significantly decreases the 
5 labor intensiveness of the method, as compared to other 
methods like PCR and ELISA. The use of a 0-galactosidase 
gene in this method allows for calorimetric detection of the 
signal, making the test instrument-free, which is another 
advantage over conventional rapid microbiological detec- 
i o  tion methods. Finally, the method described in this inven- 
tion, in which multiple assays can be produced from a single 
bacteriophage, is advantageous and cost effective because 
the assays can be produced based on a standardized plat- 
form, without the need to completely genetically and phe- 
15 notypically characterize new bacteriophage for every new 
test. 
One disadvantage of the currently available reporter bac- 
teriophage assays is the need for an instrument to detect the 
reporter protein of interest, which limits the ability of these 
20 methods to be used in the field. The present invention also 
includes a single-tube apparatus hat employs the reporter 
bacteriophage platform in an assay that is simple and easy to 
perform, inexpensive and fast. This reporter bacteriophage 
assay is self-enclosed, and detected using a choice of sub- 
25 strates. One class of these substrates (calorimetric sub- 
strates) allows for the production of a visible colorimetric 
product, eliminating the need for instrument based detection. 
SUMMARY OF THE INVENTION 
30 
The invention consists of a method for the simultaneous 
development of multiple bacterial detection assays based on 
a T4 bacteriophage system. A T4 reporter bacteriophage 
strain is used that carries several genetic mutations. First, the 
35 T4 reporter strain carries amber mutations in the genes denA 
and denB. As a result of the amber mutations in denA and 
denB, the host DNA and plasmid DNA will remain intact 
within the bacterial cell upon infection with the T4 reporter 
strain. The T4 reporter bacteriophage strain has also been 
40 genetically modified to carry a reporter gene. In a preferred 
embodiment, the reporter gene is a thermophilic 0-galac- 
tosidase gene (lacz) that has been fused, in frame, to the T4 
promoter 22. The promoter221~-galactosidase fusion is sta- 
bly integrated in a non-essential part of the T4 genome. The 
45 T4 reporter bacteriophage also has amber mutations in its 
tail genes 37 and 38 so that the T4 reporter bacteriophage is 
only capable of growth in a bacterial host strain that sup- 
presses amber mutations. In addition, the T4 reporter gene 
will only be capable of growth when mutated tail genes 37 
50 and 38 are replaced with functional genes via marker rescue. 
This invention also consists of the development of an 
assay for the rapid detection of pathogenic bacteria. Such an 
assay is capable of producing accurate results from compli- 
cated samples containing mixtures of microorganisms. This 
55 invention will address the limitations of the currently avail- 
able methods for detection of bacterial pathogens through 
the development of a one-tube system that will be capable of 
rapidly detecting viable pathogenic isolates. The detection 
system consists of two components, including a reporter 
60 bacteriophage genetically modified to carry a thermophillic 
0-galactosidase gene, and a substrate for the 0-galactosi- 
dase, which is encapsulated within temperature sensitive 
liposomes. The substrate consists of any substrate that can 
be used for detection of 0-galactosidase, including the 
65 colorimetric, fluorescent and luminogenic substrates. 
The release of drugsimolecules in an environment con- 
trolled by the use of temperature-sensitive liposomes is a 
1 
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BACKGROUND OF THE INVENTION 
The invention relates generally to platforms for the devel- 
opment of assays for the simultaneous detection of multiple 
bacteria and, more specifically, the use of the T4 bacterioph- 
age, and related T even bacteriophages, in assays for the 
simultaneous detection of human pathogenic bacteria. 
Bacteriophage within the T even family infect many 
diverse bacteria, including Escherichia coli, Salmonella 
spp., Shigella spp., Yersinia spp., Aeromonas spp., 
Burkholderia spp., Pseudomonas spp., Acinebacter spp., 
Vibrio spp., Klebsiella, spp., Citrobacter spp., Proteus spp., 
and Serratia spp. These bacteria are all important as causes 
of food spoilage, and human and animal illness. Many of 
these pathogens (E. coli, Salmonella, Shigella, Aeromonas, 
Vibrio) cause serious foodbome illness in humans. Food- 
bome illness accounts for 75 million illnesses in the U.S. 
each year. In addition, several of the pathogens described 
above (Yersinia pestis, Burkholderia spp.) are considered as 
Category A select biological agents, capable to be used as 
biological weapons. Therefore rapid and simple detection 
methods are needed to ensure the safety of the public from 
these pathogens. 
In traditional reporter bacteriophage assays, a temperate 
bacteriophage is screened against many different bacteria to 
determine its host range, followed by genome sequencing, 
and creation of a genetically modified bacteriophage. This 
process typically takes years, and needs to be repeated for 
every new assay and bacteriophage. Additionally, the meth- 
ods used to create the genetically modified bacteriophage 
typically resulted in the incorporation of an antibiotic resis- 
tance gene into the bacteriophage chromosome, which is not 
advantageous since it is possible for the genetically engi- 
neered temperate bacteriophage to transfer the antibiotic 
resistance gene to its host. 
The method described in this invention eliminates many 
of the traditional reporter bacteriophage creation steps, uses 
a lytic bacteriophage (lytic bacteriophage kill their host, so 
there is no worry about transferring virulence genes to the 
host), does not incorporate an antibiotic resistance gene into 
the bacteriophage chromosome, and allows for the creation 
of multiple detection assays within a matter of weeks to 
months as opposed to years. This also significantly decreases 
the cost of development. 
The advantages of this system over other systems are 
numerous. Since bacteriophage are only capable of growing 
in viable bacteria, the reporter bacteriophages used in this 
system are capable of distinguishing between viable and 
non-viable bacteria. This is a major advantage over conven- 
tional PCR assays and ELISA techniques. In addition, the 
technique requires only the addition of the reporter bacte- 
US 7,244,612 B2 
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novel approach. Liposomes are phospholipid vesicles and moter22i~-galactosidase fusion is stably integrated in a 
work as carriers for the delivery of molecules to cells. For non-essential part of the T4 genome. 
example, temperature sensitive liposomes have been Finally, the T4 reporter bacteriophage has amber muta- 
designed to release drugs in response to increased tempera- tions in its tail genes 37 and 38. As a result of these amber 
tures at the disease site. In this invention, the 0-galactosidase 5 mutations in the tail genes, the T4 reporter bacteriophage is 
substrates are encapsulated within temperature sensitive only capable of growth in a bacterial host strain that sup- 
liposomes, which are designed to release the substrate upon presses amber mutations, such as E. coli CR63 F’, supD60. 
an increase in temperature. The liposomes are designed so Using an amber suppressing strain such as CR63 amplifies 
that they can be specifically targeted to the surface of the the T4 reporter bacteriophage. In addition, the T4 reporter 
bacterial cell of interest. This can be achieved by incorpo- i o  gene is only capable of growth when mutated tail genes 37 
rating specific antibodies, or other targeting ligands onto the and 38 are replaced with functional genes via marker rescue. 
surface of the liposomes, so that they will attach to a given This T4 reporter bacteriophage is used in detection assays 
bacteria in a specific manner. Targeting the liposomes to the to detect bacterial pathogens in the following manner. First, 
bacterial cell surface will result in intimate contact between a T even bacteriophage that infects the bacteria of interest is 
the enzyme and substrate, allowing for an increase in 15 selected. Members of the T even bacteriophage family are 
sensitivity of the assay. genetically related to each other, with varying degrees of 
In a preferred embodiment, the assay is incorporated into homology. One area of highly conserved homology within 
a single tube, such as the Snap-Valve device sold by Medical the T even bacteriophage lies in gene 36, which is upstream 
Packaging Corporation, or any other single tube device that of the tail fiber genes (including genes 37 and 38) that are 
is designed to be used, or can be used, in conjunction with 20 required for bacterial host recognition. Another area of 
a hand held luminometer. highly conserved homology in the T even family lies in gene 
t, which is downstream of the tail fiber genes (including 
genes 37 and 38). The area between the homologous region 
of gene 36 and genet (“host range cassette”), which includes 
FIG. 1 is a diagrammatic representation of the construc- 25 the tail fiber genes, is highly variable in T even bacterioph- 
age. Even though the host range cassettes are highly variable 
in T even bacteriophage, a single PCR primer pair designed 
such that the 5‘ primer is situated in the 3’ end of gene 36, 
and the 3’ primer is situated in the 5‘ end of gene t will 
BRIEF DESCRIPTION OF THE FIGURES 
tion of a lacZ T4 reporter phage; the p2211acZ fusion is 
cloned into a plasmid, and is flanked by the T4 recombina- 
tional genetic targets; the p22/1acZ fusion integrates into the 
bacteriophage T4 chromosome via a double homologous 
recombination event between the plasmid-borne target 30 amplify the host range cassette of any T even bacteriophage 
sequences and their bacteriophage chromosomal counter- (FIG. 2). 
parts. The host range cassette of a T even bacteriophage that 
FIG. 2 is a diagrammatic representation of the construc- infects the bacteria of interest is amplified by PCR using the 
tion of a lacZ T4 reporter phage with altered host range; the above-described primers and cloned into a suitable plasmid. 
T4 phage with an integrated lacZ gene of FIG. 1, and amber 35 The plasmid is placed into the amber suppressing bacterial 
mutations in tail genes 37 and 38 (37-, 38-), is used to create host strain (CR63). The T4 reporter bacteriophage, which 
a reporter phage with an altered host range. includes the amber mutations in tail fiber genes 36 and 37, 
FIG. 3 is a diagrammatic representation of a single is used to infect the amber suppressing bacterial host strain 
compartment assay scheme of the present invention. (CR63). 
apparatus of the present invention; the average reading introduces its DNA to the host bacteria, its DNA recombines 
represents the mean of three readings per sample; standard with the plasmid containing the host range cassette. The 
deviations are also indicated; the assay was capable of plasmid borne host range cassette integrates itself into the T4 
detecting an initial inoculum of lo1 CFUilOO cm’). reporter bacteriophage chromosome via double homologous 
45 recombination (marker rescue). Bacteriophage that have 
functional tail fiber genes as a result of the marker rescue 
step are isolated by plating the bacteriophage on the bacte- 
rial host of interest, which supports the growth of the 
bacteriophage that have received the functional tail fiber 
50 genes, but cannot support the growth of the amber mutant 
In general, the method uses a T4 reporter bacteriophage bacteriophage. 
with genetic mutations to detect various bacterial pathogens. For example, in the development of a detection assay for 
A T4 reporter bacteriophage strain is used that carries Salmonella, the host range cassette from a T even bacte- 
several genetic mutations. First, the T4 reporter strain carries riophage that infects Salmonella is amplified, cloned into a 
amber mutations in the genes denA and denB. These non- 55 plasmid, the plasmid is placed into the E. coli amber 
essential genes are responsible for degrading bacterial host suppressing strain (CR63), the strain is infected with the 
and plasmid DNA upon infection of the host bacterial cell. template reporter phage, progeny phage are isolated, and 
As a result of the amber mutations in denA and denB, the bacteriophage are grown on a Salmonella strain. The Sal- 
host DNA and, most importantly, plasmid DNA remain monella strain does not allow for the template reporter phage 
intact within the bacterial cell upon infection with the T4 60 with the amber mutations in genes 37 and 38 to grow 
reporter strain. This results in much higher frequencies of (because it does not have the right host range, and wild type 
homologous recombination between plasmid borne targets strains do not usually carry suppressors for amber muta- 
and the bacteriophage chromosome. tions), but only allows bacteriophage that have functional 
As shown in FIG. 1, the T4 reporter bacteriophage strain tail fiber genes (obtained from the Salmonella T even 
has also been genetically modified to carry a reporter gene. 65 bacteriophage, by marker rescue) to grow. 
The reporter gene is a 0-galactosidase gene (lacz) which has This provides an effective system for the rapid creation of 
been fused, in frame, to the T4 promoter 22. The pro- detection assays that specifically detect different bacterial 
FIG. 4 is a chart of luminescent detection with an assay 40 As shown in FIG. 2, Once the T4 reporter bacteriophage 
DETAILED DESCRIPTION OF PREFERRED 
EMBODIMENTS 
Example I 
US 7,244,612 B2 
5 6 
pathogens, and are all based upon the same platform, which 
in the preferred embodiment is transduction of a thermo- 
philic 0-galactosidase gene. 
detection of E. coli 0157, Salmonella, and Shigella is 
comprised of three individual kits, all of which are identical 
except that the reporter bacteriophage used for detection 
have different host ranges (one each for E. coli, Salmonella, 
Example I1 5 and Shigella). The tests are performed simultaneously, 
wherein a single sample that is divided into three sections. 
Each section is placed into an individual tube, and the assay 
is performed. In this way simultaneous and specific detec- 
tion of multiple pathogens is effected. 
This invention consists of the development of an assay for 
the rapid detection of pathogenic bacteria. Such an assay is 
capable of producing accurate results from complicated 
samples containing mixtures of microorganisms. This inven- 10 
tion addresses the limitations of the currently available 
methods for detection of bacterial pathogens through the 
development of a one-tube system that is capable of rapidly An improved, self-contained single tube apparatus for 
detecting viable pathogenic isolates. The detection system carrying out the assays of the present invention has been 
consists of two components, including a reporter bacterioph- 15 developed. The reporter bacteriophage and the substrate 
age genetically modified to carry a thermophillic 0-galac- (any colorimetric substrate) are now included within a 
tosidase gene, and a substrate for the 0-galactosidase, which Snap-ValveTM device or any variation of the Snap ValveTM 
is encapsulated within temperature sensitive liposomes. The device (Medical Packaging Corporation, Calif.). The Snap- 
substrate consists of any substrate that can be used for ValveTM device also houses growth media for the bacteria, 
detection of 0-galactosidase, including the colorimetric, 20 immunomagnetic separation beads specific for the target 
fluorescent and luminogenic substrates. bacteria and a sampling device which consists of any of the 
The release of drugsimolecules in an environment con- following: swabs, scrapers, scoopers, loops, needles, honey 
trolled by the use of temperature-sensitive liposomes is a dippers, and drippers. The device containing the reporter 
novel approach. Liposomes are phospholipid vesicles and bacteriophage, 0-galactosidase substrate, bacterial growth 
work as carriers for the delivery of molecules to cells. For 25 media, immunomagnetic separation beads, and the sampling 
example, temperature sensitive liposomes have been device has been termed the Phast Swab. To test the food 
designed to release drugs in response to increased tempera- sample in question or the food contact surface, or an 
tures at the disease site. In this invention, the 0-galactosidase environmental surface (such as a drain), or any other sample, 
substrates are encapsulated within temperature sensitive the sampling device is removed from the Snap ValveTM 
liposomes, which are designed to release the substrate upon 30 device and a sample is obtained. The sampling device is 
an increase in temperature. The liposomes are designed so replaced into the Snap ValveTM and the entire device is 
that they can be specifically targeted to the surface of the incubated at 31" C. to 37" C. for 8 hours. Following the 
bacterial cell of interest. This can be achieved by incorpo- incubation step, immunomagnetic separation (IMS) is 
rating specific antibodies, or other targeting ligands onto the accomplished on the sample by placing the entire device into 
surface of the liposomes, so that they will attach to a given 35 a magnetic concentrator, allowing the IMS beads to con- 
bacteria in a specific manner. Targeting the liposomes to the centrate, and removing the growth media. Next, the bottom 
bacterial cell surface results in intimate contact between the compartment of the Snap ValveTM is punctured, releasing the 
enzyme and substrate, allowing for an increase in sensitivity reporter bacteriophage to mix with the beads. The Snap 
of the assay. ValveTM is incubated at 3 1 O C. to 37" C. for 1.5 hours, during 
The reporter phage and the temperature sensitive lipo- 40 which the reporter bacteriophage will infect any target cells 
somes are included within a single test compartment (A of present, and force them to make 0-galactosidase. Then, the 
FIG. 3). The sample to be tested is added to the compartment cap of the Snap ValveTM is broken, releasing the substrate to 
(B), whereupon the reporter bacteriophage infects any viable mix with the reporter bacteriophage, IMS-bacteria suspen- 
bacteria of interest within the sample, and force the bacteria sion. If 0-galactosidase was produced, then the substrate will 
to make large amounts of 0-galactosidase and following the 45 interact with the 0-galactosidase, causing a visual colori- 
bacteriophage life cycle (approximately one-hour) the phage metric reaction, indicating a positive result. A negative test 
will lyse the cells releasing the from the bacterial cytoplasm is indicated the absence of a visual colorimetric reaction. 
(C). Following the infection process, the temperature of the The system has been modified as described in more detail 
test compartment is increased by placing the compartment in below to be read in portable hand held luminometers. 
boiling water, causing the temperature sensitive liposomes 50 To demonstrate the effectiveness of the present assay 
to release the substrate (D), which then reacts with the apparatus, ten by ten centimeter squared portions of beef 
thermophillic 0-galactosidase (optimum temperature for (top round, sirloin tip) were inoculated with serial dilutions 
activity is 95-105" C.) to produce a signal (E). Heating the ofE. coli 0157:H7 by pipetting 1 ml of each dilution on an 
sample also causes the destruction of any pschrophillic and individual 10x10 cm2 piece of meat, followed by spreading 
mesophillic 0-glactosidases present, significantly decreasing 55 the dilution over the entire surface of the meat with a glass 
the background signal. The signal may be visual in nature hockey stick. The meat was allowed to dry for one hour, and 
(from a calorimetric substrate), or require the use of instru- then the entire surface of each meat sample was swabbed 
mentation to observe the signal (as when fluorescent or with an individual Snap-ValveTM device. The calorimetric 
luminogenic substrates are used). The nature of this detec- swab assay was performed as follows: in the colorimetric 
tion method is such that it is effective at sensitively and 60 swab assay, the swab was removed, the surface of the meat 
individually detecting a wide range of different pathogenic was swabbed and the swab was returned to the Snap- 
bacteria (depending on the host range of the reporter bac- ValveTM device, followed by an 8 hour enrichment. Follow- 
teriophage), and also distinguishes between viable, and ing enrichment, the IMS beads (with E. coli 0157 cells 
non-viable cells, since bacteriophages can only grow within attached) were concentrated, and the growth media was 
living bacteria. Also, the assay is rapid, and easy to perform. 65 removed. Following a wash step, the reporter phage was 
Assays for multiple pathogens may be included within a added (lo7 PFUlml), and the Snap-ValveTM device was 
single kit. So, for example, a kit for the simultaneous incubated at 37" C. for 1.5 hours. Finally, the cap of the 
Example I11 
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Snap-ValveTM device was broken, releasing the 0-galactosi- 
dase (CPRG) substrate into the bottom of the device, where 
it reacted with any 0-galactosidase present. A positive test 
was indicated by the development of a red color, while in a 
negative test, the color remained yellow: Two negative 
controls were included in the assay. They consisted of a cell 
only control, which contained E. coli 0157:H7 but no 
reporter phage, and a phage only control that contained the 
reporter phage, but no E. coli 0157:H7 bacteria. The results 
indicated that the assay apparatus of the present invention 
could detect an initial inoculum of 10’ CFUilOO cm2 of 
meat. 
To test the ability of the assay apparatus of the present 
invention to detect E. coli 0157:H7 in a more sensitive 
fashion, the above experiment was repeated, except that in 
this case the 0-galactosidase substrate consisted of a lumi- 
nescent substrate. At the end of the assay, the Snap-ValveTM 
device was placed into a portable hand held luminometer, 
and the results were read (FIG. 4). Using the luminescent 
substrate, the assay apparatus of the present invention was 
able to detect an initial concentration of lo1 CFUilOO cm2 
of meat. 
The foregoing description and drawings comprise illus- 
trative embodiments of the present inventions. The forego- 
ing embodiments and the methods described herein may 
vary based on the ability, experience, and preference of those 
skilled in the art. Merely listing the steps of the method in 
a certain order does not constitute any limitation on the order 
of the steps of the method. The foregoing description and 
drawings merely explain and illustrate the invention, and the 
invention is not limited thereto, except insofar as the claims 
are so limited. Those skilled in the art who have the 
disclosure before them will be able to make modifications 
and variations therein without departing from the scope of 
the invention. 
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I claim: 
1. An assay kit for detecting the presence of viable target 
bacteria in a sample, comprising: 
(a) a container for the sample; 
(b) media in the container which supports growth of the 
target bacteria; 
(c) specific separation beads in the container to concen- 
trate the target bacteria; 
(d) a sampling device within the container to rapidly 
obtain the sample to be tested; 
(e) a lytic reporter phage in the container capable of 
infecting a viable target bacterium in the sample which 
upon incubation produces the reporter; and 
(f) a detector substrate released into the media which 
produces a signal in the presence of the reporter. 
2. The assay kit as defined in claim 1, wherein the detector 
20 substrate is contained in a capsule that releases the substrate 
upon heating of the media to an elevated temperature 
following incubation of the sample. 
3. The assay kit as defined in claim 2, wherein the capsule 
4. The assay kit as defined in claim 1, wherein the phage 
contains a DNA sequence derived from the host range 
cassette of the target bacteria. 
5. The assay kit as defined in claim 1, wherein the reporter 
is 0-galactosidase. 
6. The assay kit as defined in claim 1, wherein the lytic 
phage is a T4 phage. 
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25 is a liposome. 
30 . 
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